Structure-/disease-modifying agents for osteoarthritis

Roy D. Altman

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


OA is the most common articular disease. Age is its most notable risk factor. With the aging of the population of the developed world, there will be a growing need for better understanding of OA and for superior therapies. There is increasing appreciation for the role of inflammation in OA. There also is the realization that OA is not only a disease of cartilage, but of the entire joint. This has led to increasing interest in structure/disease modification as the goal in OA therapy. However, there are no universally proven structure-/disease-modifying interventions.

Original languageEnglish (US)
Pages (from-to)3-5
Number of pages3
JournalSeminars in Arthritis and Rheumatism
Issue number6 SUPPL.
StatePublished - Oct 2004

ASJC Scopus subject areas

  • Rheumatology
  • Anesthesiology and Pain Medicine


Dive into the research topics of 'Structure-/disease-modifying agents for osteoarthritis'. Together they form a unique fingerprint.

Cite this